Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 25.57M | $134.0M | 6.93% | +18.74M | 2026-06-30 |
| Deep Track Capital, LP | 14.42M | $75.0M | 3.90% | +2.42M | 2026-06-30 |
| Vanguard Capital Management LLC | 11.75M | $61.0M | 3.18% | -14.1K | 2026-06-30 |
| State Street Corp | 8.29M | $43.0M | 2.24% | +7.14M | 2026-06-30 |
| Geode Capital Management, LLC | 6.93M | $36.0M | 1.88% | +4.42M | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 5.64M | $29.0M | 1.53% | -- | 2026-06-30 |
| UBS Group AG | 4.42M | $23.0M | 1.20% | -3.00M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4.11M | $21.0M | 1.11% | -- | 2026-06-30 |
| Morgan Stanley | 3.84M | $20.0M | 1.04% | -9.5K | 2026-06-30 |
| Candriam S.C.A. | 3.04M | $16.0M | 0.82% | -47.0K | 2026-06-30 |
